CVS Health Corporation Company Profile (NYSE:CVS)

About CVS Health Corporation (NYSE:CVS)

CVS Health Corporation logoCVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc. (Omnicare) and Omnicare's long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings. It operates through three segments: Pharmacy Services, Retail/LTC and Corporate. The Pharmacy Services Segment provides a range of pharmacy benefit management (PBM) solutions to its clients. As of December 31, 2016, the Retail/LTC Segment included 9,709 retail locations (of which 7,980 were its stores that operated a pharmacy and 1,674 were its pharmacies located within Target Corporation (Target) stores), its online retail pharmacy Websites,, and, 38 onsite pharmacy stores, its long-term care pharmacy operations and its retail healthcare clinics.

Industry, Sector and Symbol:
  • Sector: Retail/Wholesale
  • Industry: Drug Retailers
  • Sub-Industry: Drug Retail
  • Symbol: NYSE:CVS
  • CUSIP: 12665010
  • Web:
  • Market Cap: $80.95 billion
  • Outstanding Shares: 1,016,564,000
Average Prices:
  • 50 Day Moving Avg: $79.11
  • 200 Day Moving Avg: $78.98
  • 52 Week Range: $69.30 - $90.85
  • Trailing P/E Ratio: 15.86
  • Foreward P/E Ratio: 12.52
  • P/E Growth: 1.68
Sales & Book Value:
  • Annual Revenue: $180.79 billion
  • Price / Sales: 0.45
  • Book Value: $33.64 per share
  • Price / Book: 2.37
  • Annual Dividend: $2.00
  • Dividend Yield: 2.5%
  • EBIDTA: $12.65 billion
  • Net Margins: 2.93%
  • Return on Equity: 17.47%
  • Return on Assets: 6.58%
  • Debt-to-Equity Ratio: 0.75%
  • Current Ratio: 1.09%
  • Quick Ratio: 0.56%
  • Average Volume: 5.31 million shs.
  • Beta: 0.92
  • Short Ratio: 3.89

Frequently Asked Questions for CVS Health Corporation (NYSE:CVS)

What is CVS Health Corporation's stock symbol?

CVS Health Corporation trades on the New York Stock Exchange (NYSE) under the ticker symbol "CVS."

How often does CVS Health Corporation pay dividends? What is the dividend yield for CVS Health Corporation?

CVS Health Corporation declared a quarterly dividend on Tuesday, September 19th. Shareholders of record on Tuesday, October 24th will be paid a dividend of $0.50 per share on Friday, November 3rd. This represents a $2.00 dividend on an annualized basis and a yield of 2.51%. The ex-dividend date of this dividend is Monday, October 23rd. View CVS Health Corporation's Dividend History.

How were CVS Health Corporation's earnings last quarter?

CVS Health Corporation (NYSE:CVS) released its quarterly earnings data on Tuesday, August, 8th. The company reported $1.33 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.31 by $0.02. The business earned $45.69 billion during the quarter, compared to the consensus estimate of $45.36 billion. CVS Health Corporation had a return on equity of 17.47% and a net margin of 2.93%. CVS Health Corporation's revenue was up 4.5% on a year-over-year basis. During the same period in the previous year, the firm earned $1.32 earnings per share. View CVS Health Corporation's Earnings History.

When will CVS Health Corporation make its next earnings announcement?

CVS Health Corporation is scheduled to release their next quarterly earnings announcement on Tuesday, November, 14th 2017. View Earnings Estimates for CVS Health Corporation.

What guidance has CVS Health Corporation issued on next quarter's earnings?

CVS Health Corporation issued an update on its FY17 earnings guidance on Tuesday, August, 8th. The company provided EPS guidance of $5.83-5.93 for the period, compared to the Thomson Reuters consensus EPS estimate of $5.87. CVS Health Corporation also updated its Q3 guidance to $1.47-1.50 EPS.

Where is CVS Health Corporation's stock going? Where will CVS Health Corporation's stock price be in 2017?

20 analysts have issued 12-month price targets for CVS Health Corporation's stock. Their predictions range from $82.00 to $111.00. On average, they expect CVS Health Corporation's share price to reach $90.82 in the next year. View Analyst Ratings for CVS Health Corporation.

What are analysts saying about CVS Health Corporation stock?

Here are some recent quotes from research analysts about CVS Health Corporation stock:

  • 1. Guggenheim analysts commented, " Our recent meetings with CEO Larry Merlo, CFO Dave Denton, and VP-IR Nancy Christal further reinforced our confidence in 10% secular growth, which we believe the market is currently undervaluing, at a 13x P/E on somewhat depressed 2017E EPS. Bottom line, even in the face of secular gross margin erosion, in both segments, we believe the company should be able to grow EBIT by 5% on the back of a) natural growth in specialty Rx, b) increasingly rapid product innovation, c) a broadening set of productive relationships, and d) both COGS and SG&A reductions. In our view, this growth merits a valuation closer to a market multiple'we reiterate our Buy rating and $90 PT, implying 15% upside from current levels." (3/28/2017)
  • 2. Evercore ISI analysts commented, "While the quarter proved generally uneventful and guidance was reiterated on the surface (albeit some moving parts below ' dollar profit targets were unchanged in our view ' much of the delta related to where 4Q came out vs mid-point and lower inflation outlook), investors have reacted negatively to the lack of clarity on several key issues with respect to business model risk that in our minds is unlikely to dissipate until later in the year. We think management did an admirable job on the DIR fee issue and a reasonable job on gross to net / rebates, but the reality is that policy noise is unlikely to dissipate and the outlook for 2018 won't start to gain clarity until the summer. We think once we get initial color on the PBM selling season, a better understanding of underlying pharmacy share shifts and profit headwinds and ultimately gain a better picture of 2018 the multiple may start to see some relief. Until then CVS shares remain inexpensive and highly leveraged to tax reform and it appears as if many years of execution are being overshadowed by a tough 18 month stretch. Given how far shares have fallen and in our view strong FCF yield support we retain our Buy rating but acknowledge the path to returns from here is likely most appropriate for those with a multi-year time horizon and a 'deep value' focus." (2/9/2017)

Who are some of CVS Health Corporation's key competitors?

Who are CVS Health Corporation's key executives?

CVS Health Corporation's management team includes the folowing people:

  • David Wyatt Dorman, Independent Chairman of the Board
  • Larry J. Merlo, President, Chief Executive Officer, Director
  • David M. Denton, Chief Financial Officer, Executive Vice President
  • Jonathan C. Roberts, Chief Operating Officer, Executive Vice President
  • Lisa G. Bisaccia, Chief Human Resource Officer, Executive Vice President
  • Stephen J. Gold, Executive Vice President, Chief Information Officer
  • Thomas M. Moriarty, Executive Vice President, General Counsel, Chief Health Strategy Officer
  • Troyen A. Brennan M.D., Executive Vice President, Chief Medical Officer
  • Helena B. Foulkes, Executive Vice President, President of CVS - Pharmacy
  • J. David Joyner, Executive Vice President

Who owns CVS Health Corporation stock?

CVS Health Corporation's stock is owned by a number of of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (7.51%), BlackRock Inc. (6.05%), State Street Corp (4.30%), FMR LLC (2.96%), Northern Trust Corp (1.53%) and Nordea Investment Management AB (1.39%). Company insiders that own CVS Health Corporation stock include Andrew Sussman, David M Denton, Eva C Boratto, Helena Foulkes, Jonathan C Roberts, Larry J Merlo, Richard J Swift, Stephen J Gold, Thomas M Moriarty and Troyen A Brennan. View Institutional Ownership Trends for CVS Health Corporation.

Who sold CVS Health Corporation stock? Who is selling CVS Health Corporation stock?

CVS Health Corporation's stock was sold by a variety of institutional investors in the last quarter, including The Manufacturers Life Insurance Company , Arrowstreet Capital Limited Partnership, BlackRock Inc., Ameriprise Financial Inc., Pioneer Investment Management Inc., TIAA CREF Investment Management LLC, Bank of New York Mellon Corp and Alliancebernstein L.P.. Company insiders that have sold CVS Health Corporation stock in the last year include Andrew Sussman, David M Denton, Eva C Boratto, Helena Foulkes, Jonathan C Roberts, Larry J Merlo, Richard J Swift, Thomas M Moriarty and Troyen A Brennan. View Insider Buying and Selling for CVS Health Corporation.

Who bought CVS Health Corporation stock? Who is buying CVS Health Corporation stock?

CVS Health Corporation's stock was acquired by a variety of institutional investors in the last quarter, including FMR LLC, Boston Partners, Parametric Portfolio Associates LLC, Prudential Financial Inc., Nordea Investment Management AB, Vanguard Group Inc., Brandywine Global Investment Management LLC and Canada Pension Plan Investment Board. View Insider Buying and Selling for CVS Health Corporation.

How do I buy CVS Health Corporation stock?

Shares of CVS Health Corporation can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is CVS Health Corporation's stock price today?

One share of CVS Health Corporation stock can currently be purchased for approximately $79.63.

MarketBeat Community Rating for CVS Health Corporation (NYSE CVS)
Community Ranking:  3.5 out of 5 (star star star half star)
Outperform Votes:  841 (Vote Outperform)
Underperform Votes:  345 (Vote Underperform)
Total Votes:  1,186
MarketBeat's community ratings are surveys of what our community members think about CVS Health Corporation and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for CVS Health Corporation (NYSE:CVS) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 7 Hold Ratings, 13 Buy Ratings
Consensus Rating:Buy (Score: 2.65)
Consensus Price Target: $90.82 (14.05% upside)

Analysts' Ratings History for CVS Health Corporation (NYSE:CVS)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
9/19/2017Royal Bank Of CanadaInitiated CoverageOutperform -> Outperform$95.00LowView Rating Details
9/15/2017Jefferies Group LLCBoost Price TargetHold -> Hold$82.00 -> $86.00MediumView Rating Details
9/10/2017Needham & Company LLCReiterated RatingHoldLowView Rating Details
8/24/2017Loop CapitalInitiated CoverageHold -> Hold$83.00LowView Rating Details
8/17/2017Citigroup Inc.Lower Price TargetNeutral$88.00 -> $87.00LowView Rating Details
8/14/2017Robert W. BairdReiterated RatingOutperform$90.00LowView Rating Details
8/14/2017Wolfe ResearchDowngradeOutperform -> Market Perform$89.00 -> $82.00LowView Rating Details
7/3/2017GuggenheimReiterated RatingBuyLowView Rating Details
6/27/2017Leerink SwannSet Price TargetBuy$90.00N/AView Rating Details
6/13/2017Cowen and CompanyReiterated RatingOutperform$86.00LowView Rating Details
5/3/2017Evercore ISIReiterated RatingOutperform$87.00 -> $88.00LowView Rating Details
4/27/2017Tigress FinancialInitiated CoverageBuy -> BuyLowView Rating Details
2/28/2017Bank of America CorporationReiterated RatingBuy$106.67N/AView Rating Details
2/8/2017Deutsche Bank AGReiterated RatingHold$88.00N/AView Rating Details
2/6/2017Atlantic SecuritiesDowngradeOverweight -> Neutral$84.00N/AView Rating Details
12/19/2016Credit Suisse GroupReiterated RatingBuyN/AView Rating Details
12/18/2016Oppenheimer Holdings, Inc.Set Price TargetBuy$88.00N/AView Rating Details
11/10/2016ArgusReiterated RatingBuy$120.00 -> $85.00N/AView Rating Details
11/9/2016Barclays PLCReiterated RatingBuy$85.00N/AView Rating Details
11/9/2016MizuhoBoost Price TargetBuy$90.00 -> $111.00N/AView Rating Details
9/12/2016Morgan StanleyReiterated RatingHold$104.00N/AView Rating Details
8/3/2016FBR & CoReiterated RatingOutperform$120.00N/AView Rating Details
5/5/2016MacquarieReiterated RatingOutperform$115.00N/AView Rating Details
2/10/2016Goldman Sachs Group, Inc. (The)Boost Price TargetNeutral$106.00 -> $110.00N/AView Rating Details
11/3/2015S&P Equity ResearchUpgradeStrong-Buy$121.00N/AView Rating Details
11/2/2015Raymond James Financial, Inc.Boost Price TargetOutperform$105.00 -> $110.00N/AView Rating Details
11/2/2015BMO Capital MarketsBoost Price TargetOutperform$103.00 -> $113.00N/AView Rating Details
11/2/2015J P Morgan Chase & CoLower Price TargetOverweight$128.00 -> $123.00N/AView Rating Details
(Data available from 9/24/2015 forward)


Earnings History for CVS Health Corporation (NYSE:CVS)
Earnings by Quarter for CVS Health Corporation (NYSE:CVS)
Earnings History by Quarter for CVS Health Corporation (NYSE CVS)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/6/2017$1.49N/AView Earnings Details
8/8/2017Q2 2017$1.31$1.33$45.36 billion$45.69 billionViewListenView Earnings Details
5/2/2017Q1 2017$1.10$1.17$44.20 billion$44.51 billionViewListenView Earnings Details
2/9/2017Q416$1.67$1.71$46.56 billion$46.00 billionViewListenView Earnings Details
11/8/2016Q316$1.57$1.64$45.29 billion$44.60 billionViewListenView Earnings Details
8/2/2016Q216$1.30$1.32$44.28 billion$43.70 billionViewN/AView Earnings Details
5/3/2016Q116$1.16$1.18$43.01 billion$43.20 billionViewN/AView Earnings Details
2/9/2016Q415$1.53$1.53$41.12 billion$41.15 billionViewN/AView Earnings Details
10/30/2015Q315$1.29$1.28$37.81 billion$38.50 billionViewListenView Earnings Details
8/4/2015Q215$1.20$1.22$37.18 billion$37.20 billionViewN/AView Earnings Details
5/1/2015Q115$1.08$1.14$35.93 billion$36.30 billionViewN/AView Earnings Details
2/10/2015Q414$1.21$1.21$36.06 billion$37.06 billionViewN/AView Earnings Details
11/4/2014Q314$1.13$1.15$34.74 billion$35.00 billionViewN/AView Earnings Details
8/5/2014Q214$1.10$1.13$33.47 billion$34.60 billionViewN/AView Earnings Details
5/2/2014Q114$1.05$1.02$32.31 billion$32.70 billionViewN/AView Earnings Details
2/11/2014Q413$1.11$1.12$32.67 million$32.80 millionViewN/AView Earnings Details
11/5/2013Q313$1.02$1.05$31.53 billion$32.00 billionViewListenView Earnings Details
8/6/2013Q2 2013$0.96$0.97$31.13 billion$31.25 billionViewListenView Earnings Details
5/1/2013Q113$0.79$0.83$30.36 billion$30.76 billionViewListenView Earnings Details
2/6/2013Q4 2012$1.10$1.14$31.13 billion$31.40 billionViewListenView Earnings Details
11/6/2012Q312$0.84$0.85$30.09 billion$30.23 billionViewN/AView Earnings Details
8/7/2012$0.80$0.81ViewN/AView Earnings Details
5/2/2012$0.63$0.65ViewN/AView Earnings Details
11/3/2011$0.68$0.70ViewN/AView Earnings Details
8/4/2011$0.65$0.65ViewN/AView Earnings Details
5/5/2011$0.55$0.57ViewN/AView Earnings Details
2/3/2011$0.79$0.80ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for CVS Health Corporation (NYSE:CVS)
2017 EPS Consensus Estimate: $5.90
2018 EPS Consensus Estimate: $6.49
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20174$1.09$1.33$1.18
Q2 20174$1.30$1.32$1.31
Q3 20175$1.47$1.64$1.51
Q4 20175$1.87$1.91$1.89
Q1 20184$1.12$1.49$1.30
Q2 20184$1.43$1.62$1.48
Q3 20183$1.65$1.82$1.73
Q4 20183$1.89$2.05$1.98
Q1 20192$1.24$1.35$1.30
Q2 20192$1.54$1.59$1.57
(Data provided by Zacks Investment Research)


Current Dividend Information for CVS Health Corporation (NYSE:CVS)
Next Dividend:11/3/2017
Annual Dividend:$2.00
Dividend Yield:2.51%
Dividend Growth:23.60% (3 Year Average)
Payout Ratio:39.92% (Trailing 12 Months of Earnings)
34.01% (Based on This Year's Estimates)
31.45% (Based on Next Year's Estimates)
Track Record:9 Years of Consecutive Dividend Growth
Dividend Payments by Quarter for CVS Health Corporation (NYSE:CVS)

Dividend History by Quarter for CVS Health Corporation (NYSE CVS)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for CVS Health Corporation (NYSE:CVS)
Insider Ownership Percentage: 0.61%
Institutional Ownership Percentage: 81.49%
Insider Trades by Quarter for CVS Health Corporation (NYSE:CVS)
Institutional Ownership by Quarter for CVS Health Corporation (NYSE:CVS)
Insider Trades by Quarter for CVS Health Corporation (NYSE:CVS)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/18/2017Jonathan C RobertsCOOSell85,743$83.14$7,128,673.02View SEC Filing  
9/15/2017Helena FoulkesEVPSell39,340$81.88$3,221,159.20View SEC Filing  
9/13/2017Larry J MerloInsiderSell241,150$83.07$20,032,330.50View SEC Filing  
9/11/2017David M DentonCFOSell237,078$79.65$18,883,262.70View SEC Filing  
9/11/2017Thomas M MoriartyEVPSell90,267$79.61$7,186,155.87View SEC Filing  
8/16/2017Richard J SwiftDirectorSell2,500$79.62$199,050.00View SEC Filing  
6/26/2017Helena FoulkesEVPSell20,333$80.00$1,626,640.00View SEC Filing  
6/19/2017Helena FoulkesEVPSell20,332$76.98$1,565,157.36View SEC Filing  
6/12/2017David M DentonCFOSell230,510$80.00$18,440,800.00View SEC Filing  
3/21/2017Troyen A BrennanEVPSell23,849$78.73$1,877,631.77View SEC Filing  
3/17/2017Eva C BorattoEVPSell6,029$79.60$479,908.40View SEC Filing  
3/13/2017Andrew SussmanEVPSell14,104$80.40$1,133,961.60View SEC Filing  
3/10/2017David M DentonCFOSell95,618$80.68$7,714,460.24View SEC Filing  
2/16/2017Jonathan C RobertsEVPSell61,196$80.00$4,895,680.00View SEC Filing  
5/5/2016Larry J MerloCEOSell38,247$105.00$4,015,935.00View SEC Filing  
5/5/2016Troyen A BrennanEVPSell7,517$105.00$789,285.00View SEC Filing  
4/1/2016Stephen J GoldEVPSell21,922$105.00$2,301,810.00View SEC Filing  
3/9/2016Larry J MerloCEOSell38,247$100.00$3,824,700.00View SEC Filing  
2/11/2016Jonathan C. RobertsEVPSell23,355$92.86$2,168,745.30View SEC Filing  
2/1/2016Larry J. MerloCEOSell46,393$96.14$4,460,223.02View SEC Filing  
1/11/2016Larry J. MerloCEOSell46,393$95.00$4,407,335.00View SEC Filing  
10/27/2015Troyen A. BrennanEVPSell23,603$105.00$2,478,315.00View SEC Filing  
7/20/2015Eva C BorattoSVPSell22,107$110.34$2,439,286.38View SEC Filing  
7/15/2015Lisa BisacciaEVPSell49,908$110.00$5,489,880.00View SEC Filing  
6/1/2015C David Brown IIDirectorSell10,000$102.57$1,025,700.00View SEC Filing  
5/1/2015C David Brown IIDirectorSell15,000$100.27$1,504,050.00View SEC Filing  
4/10/2015Andrew SussmanEVPSell17,638$102.38$1,805,778.44View SEC Filing  
4/2/2015Troyen A BrennanEVPSell33,384$102.48$3,421,192.32View SEC Filing  
3/23/2015Troyen A BrennanEVPSell33,274$104.94$3,491,773.56View SEC Filing  
3/20/2015C David Brown IIDirectorSell25,000$104.30$2,607,500.00View SEC Filing  
1/7/2015Jonathan C RobertsEVPSell86,487$95.31$8,243,075.97View SEC Filing  
1/5/2015Larry J MerloCEOSell144,144$94.30$13,592,779.20View SEC Filing  
1/2/2015Andrew SussmanSVPSell4,220$95.67$403,727.40View SEC Filing  
1/2/2015Per Gh LofbergEVPSell347,343$95.28$33,094,841.04View SEC Filing  
11/7/2014Helena FoulkesEVPSell46,325$88.06$4,079,379.50View SEC Filing  
10/27/2014Lisa BisacciaSVPSell33,507$85.00$2,848,095.00View SEC Filing  
9/2/2014Andrew SussmanSVPSell9,020$79.45$716,639.00View SEC Filing  
8/6/2014J. David JoynerEVPSell123,516$76.10$9,399,567.60View SEC Filing  
7/21/2014Eva C BorattoSVPSell22,107$76.77$1,697,154.39View SEC Filing  
7/1/2014David M DentonCFOSell74,989$75.88$5,690,165.32View SEC Filing  
4/2/2014Eva BorattoSVPSell17,108$74.51$1,274,717.08View SEC Filing  
3/31/2014Troyen BrennanEVPSell18,867$74.33$1,402,384.11View SEC Filing  
1/3/2014David DentonCFOSell14,113$70.50$994,966.50View SEC Filing  
1/3/2014Per Gh LofbergEVPSell790,888$70.54$55,789,239.52View SEC Filing  
1/2/2014Jonathan RobertsEVPSell162,192$70.61$11,452,377.12View SEC Filing  
1/2/2014Larry MerloCEOSell228,875$70.76$16,195,195.00View SEC Filing  
12/10/2013Lisa BisacciaSVPSell12,057$68.00$819,876.00View SEC Filing  
11/18/2013Troyen BrennanEVPSell35,387$65.61$2,321,741.07View SEC Filing  
10/18/2013Eva C BorattoSVPSell11,053$60.50$668,706.50View SEC Filing  
10/11/2013Eva BorattoSVPSell11,053$59.50$657,653.50View SEC Filing  
9/13/2013Helena FoulkesEVPSell53,546$60.00$3,212,760.00View SEC Filing  
9/9/2013Helena FoulkesEVPSell47,568$58.65$2,789,863.20View SEC Filing  
9/4/2013Andrew SussmanSVPSell9,020$58.36$526,407.20View SEC Filing  
10/4/2012Andrew SussmanSVPSell9,020$49.00$441,980.00View SEC Filing  
10/1/2012Thomas M MoriartyEVPBuy6,164$48.67$300,001.88View SEC Filing  
9/13/2012David M DentonCFOSell11,526$47.00$541,722.00View SEC Filing  
8/21/2012Jean Pierre MillonDirectorSell33,726$45.73$1,542,289.98View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for CVS Health Corporation (NYSE:CVS)
Latest Headlines for CVS Health Corporation (NYSE:CVS)
DateHeadline logoCVS Health Corporation (CVS) Given Average Rating of "Buy" by Brokerages - September 23 at 2:44 PM logoCVS Health Corporation Shares Cross Below 200 DMA - September 22 at 9:45 PM logo[$$] CVS Insiders Sell $100 Million in Stock - September 22 at 9:44 PM logoCVS Is Taking a Big Stand in the Fight Against Opioid Abuse - September 22 at 4:43 PM logoCVS Insiders Sell $100 Million in Stock - Barron's - September 22 at 9:19 AM logoCVS Health Moves to Limit Access to Opioid Painkillers - Wall Street Journal (subscription) - September 21 at 5:42 PM logo[$$] CVS Health Moves to Limit Access to Opioid Painkillers - September 21 at 5:42 PM logoHow CVS Health Is Fighting The Opioid Addiction Epidemic - September 21 at 5:42 PM logo[$$] The Morning Risk Report: Risk Managers Lack Skills to Handle Data - September 21 at 9:50 AM logoCVS Health Increases Restrictions On Opioids - September 21 at 9:50 AM logoWalgreens and CVS Fall, Amazon Eyes Pharmacy Benefit Business - September 21 at 9:50 AM logoPremarket analyst action - healthcare new coverage - Seeking Alpha - September 20 at 3:49 AM logoRoyal Bank of Canada Begins Coverage on CVS Health Corporation (CVS) - September 19 at 11:32 PM logoCVS Health Corporation (CVS) COO Jonathan C. Roberts Sells 85,743 Shares - September 19 at 7:22 PM logoInsider Selling: CVS Health Corporation (CVS) EVP Sells 39,340 Shares of Stock - September 19 at 7:22 PM logoCVS Health Corporation Announces Quarterly Dividend - PR Newswire (press release) - September 19 at 5:42 PM logoCVS Health Announces Support for Critical Rebuilding Efforts Following Historic Hurricanes - September 19 at 5:42 PM logoWalgreens gets regulatory nod for slimmed-down Rite Aid deal - September 19 at 5:42 PM logoCVS Health Corporation Announces Quarterly Dividend - September 19 at 5:42 PM logoCVS Health Corporation (CVS) Announces $0.50 Quarterly Dividend - September 19 at 2:50 PM logoCVS Health Corporation Expected to Earn Q1 2019 Earnings of $1.35 Per Share (CVS) - September 18 at 8:26 AM logoCVS Health Corporation (CVS) to Post FY2017 Earnings of $5.88 Per Share, Jefferies Group Forecasts - September 18 at 3:20 AM logoCvs Health Corp (CVS) President and CEO Larry J Merlo Sold $20 million of Shares - September 15 at 11:09 PM logoCVS Health Corporation (CVS) Insider Sells $20,032,330.50 in Stock - September 15 at 7:24 PM logoJefferies Group LLC Boosts CVS Health Corporation (CVS) Price Target to $86.00 - September 15 at 6:46 PM logoCPI Jumps 0.4% On Energy, But Grocery Prices Fall; Thanks Due To Amazon? - September 14 at 6:32 PM logo'Consumerization' has retailers disrupting the health care model, say experts at Inmar forum - September 14 at 12:00 AM logoCVS Health Corp. (CVS) Broke Out To A 4-Month High - September 14 at 12:00 AM logoCVS Health Gains on Pharmacy Services, Retail Remains a Drag - Nasdaq - September 13 at 6:59 PM logo$46.24 Billion in Sales Expected for CVS Health Corporation (CVS) This Quarter - September 13 at 5:50 AM logoCVS Health Corporation (CVS) EVP Thomas M. Moriarty Sells 90,267 Shares - September 12 at 7:34 PM logoCVS Health Corporation (CVS) CFO Sells $18,883,262.70 in Stock - September 12 at 7:32 PM logoCVS Offers Basic Items In Vending Machines - September 12 at 6:22 PM logoCVS Health Makes Overdose-Reversal Drug Available Without Individual Prescription at CVS Pharmacy Locations in Kansas - September 12 at 6:22 PM logoCVS Health and the CVS Health Foundation Announce $125,000 Towards Hurricane Irma Recovery Effort - September 12 at 6:22 PM logoCVS Health Corporation (CVS) Stock Rating Reaffirmed by Needham & Company LLC - September 11 at 8:24 PM logoSlash Your Medicare Drug Costs With These 6 Tips - September 11 at 6:18 PM logoNew CVS Vending Machines Are Total Life Savers - September 9 at 10:23 PM logoFive Solid Payout Plays: Texas Instruments, CVS, PNC, Medtronic, Sysco - September 9 at 5:20 PM logoCVS Health To Host Pittsburgh Area Job Fair To Fill More Than 200 New Full-Time Positions - September 9 at 5:20 PM logo[$$] Five Solid Payout Plays - September 9 at 4:10 AM logoCVS Health hiring 200 in Pittsburgh - Pittsburgh Business Times - September 8 at 6:05 PM logoCVS Pharmacy Thinks "Outside the Box" with Introduction of Health and Wellness Vending Machines - September 7 at 5:42 PM logoCVS Pharmacy Addressing Access, Affordability and Quality Care with Annual Free Health Screening Campaign - September 6 at 5:40 PM logoCVS Pharmacy Assisting Customers in Preparing for Hurricane Irma - September 6 at 5:39 PM logoThis Fort Worth startup convinced CVS in 10 minutes to sell its product - Dallas Business Journal - September 6 at 12:20 AM logoCareFirst BCBS re-ups with CVS Caremark - Seeking Alpha - September 6 at 12:20 AM logoCVS sets up pop-up pharmacies for Harvey victims - September 5 at 7:17 PM logoCVS Pharmacy Deploys Additional Pharmacy Resources to Impacted Communities Following Hurricane Harvey - September 5 at 7:17 PM logoCVS Health To Present At The Morgan Stanley Global Healthcare Conference - September 1 at 5:57 PM



CVS Health Corporation (CVS) Chart for Sunday, September, 24, 2017

This page was last updated on 9/24/2017 by Staff